Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone during pregnancy.

P Strunge1, J Frandsen, F Andreasen

  • 1Medical Department, Horsens Sygehus, Denmark.

European Heart Journal
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of age, sex and cardiorespiratory fitness on maximal fat oxidation rate.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2021
Same author

Healthcare's latest development in Denmark.

Sygekassetidende·2014
Same author

Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging.

Acta psychiatrica Scandinavica·2013
Same author

Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression.

Psychological medicine·2009
Same author

Dynamic changes in corticospinal tracts after stroke detected by fibretracking.

Journal of neurology, neurosurgery, and psychiatry·2007
Same author

Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover.

Journal of internal medicine·2005
Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026
Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026
Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026
Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026
Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026
Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026
See all related articles

Amiodarone (A) use during pregnancy and breastfeeding is explored. The study found no adverse effects on the infant, suggesting amiodarone can be safely administered with careful monitoring.

Area of Science:

  • Cardiology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Amiodarone (A) is an antiarrhythmic drug with potential risks during pregnancy.
  • Limited data exists on amiodarone's safety profile throughout gestation and lactation.

Observation:

  • A case study monitored thyroid function, amiodarone (A), and desethylamiodarone (DEA) serum levels in a mother and infant.
  • Infant observation extended from birth to two months, including analysis of breast milk for A and DEA concentrations.

Findings:

  • Transplacental passage of amiodarone (A) was confirmed, with significant levels detected in breast milk.
  • The infant remained healthy, euthyroid, and free of goiter or corneal deposits, showing no adverse effects on growth or thyroid function.

Related Experiment Videos

Implications:

  • Amiodarone (A) may be safely used during pregnancy and breastfeeding, provided low doses are employed.
  • Regular monitoring of serum concentrations is recommended for pregnant and lactating individuals on amiodarone therapy.